OptiNose Q2 EPS $0.02 Beats $(0.11) Estimate, Sales $19.45M Beat $17.36M Estimate
Portfolio Pulse from Benzinga Newsdesk
OptiNose (NASDAQ:OPTN) reported Q2 earnings of $0.02 per share, beating the analyst consensus estimate of $(0.11) by 118.18%. This is a 108.7% increase over losses of $(0.23) per share from the same period last year. The company also reported quarterly sales of $19.45 million, beating the analyst consensus estimate of $17.36 million by 12.06%, but this is a 5.48% decrease over sales of $20.58 million the same period last year.
August 10, 2023 | 11:03 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
OptiNose reported better than expected Q2 earnings and sales, but sales were down 5.48% YoY.
OptiNose reported Q2 earnings that significantly beat analyst estimates, which is likely to have a positive impact on the stock. However, the decrease in sales compared to the same period last year might temper this positive impact.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100